Skip to main content

Industrial Apparatuses in Confrontation

From the series The struggle against coronavirus

According to the British analyst firm Airfinity, some 9.5 billion doses of Covid-19 vaccines will be produced worldwide in 2021. This number is double the annual production of all types of vaccines in the pre-pandemic era (5 billion, excluding oral polio, travellers’ and military vaccines), and can be compared with the requirement of 11.5 billion to immunise two-thirds of the world’s population [Airfinity, March 8th]. The development of vaccines has been exceptionally rapid, but manufacturing them on a large scale has encountered difficulties and delays. In 2020, only 4% of the expected doses were in fact produced [ibidem].

Production is concentrated in a limited number of countries, largely interdependent due to supply chains that cross state borders and continents. The World Bank identifies, among the producing countries, a Covid-19 vaccine producers club of 13 countries that manufacture both the active ingredient and its components. This exclusive Vaccine Club is also awarded 60% of the total Advance Purchase Agreements (APAs) — the advance purchase of vaccines — with pharmaceutical companies [World Bank, The Covid-19 vaccine production club, March 2021].

The World Bank’s concern is that aggressive forms of vaccine nationalism , by limiting exports, are disrupting global supply chains. For its part, the World Health Organization (WHO) fears that in much of the world, such as in Africa, vaccines will not arrive until 2023 or 2024.

Crippled internationalism

In June last year, the Global Vaccine Alliance (GAVI), together with the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO, launched the COVAX programme. It covers 192 countries, with the aim of ensuring equitable global distribution of vaccines, initially providing two billion doses, two-thirds free of charge, to 92 lower-income countries. Donations were in short supply and, two months into the vaccination campaign, COVAX had still not been able to deliver a single dose to the poorest countries [Financial Times, February 13th]. Initially conceived as a single clearing house for vaccine orders around the world, from which all countries, rich and poor, would procure their doses, notes the City newspaper, the program almost immediately foundered in the race for bilateral deals between the richest nations and the vaccine companies, and the priority allocation to domestic needs practised by countries like the United States, the UK and, more recently, even India.

Limited production, coupled with the supply dispute that has arisen between the European Commission and pharmaceutical companies — in particular with the Anglo-Swedish company AstraZeneca — has prompted several European leaders (and various scientific and political figures) to raise the issue of patents. The President of the European Council Charles Michel at the beginning of the year raised the possibility of the EU adopting ‘urgent measures’ — provided for in Article 122 of the Treaty — to impose ‘compulsory licensing’ on companies [Politico, February 3rd]. In fact, last December, the request made by some countries, including India and South Africa, for companies to waive patent exclusivity was rejected by the United States, the UK and the EU [The New York Times, December 25th].

The protection of intellectual property is regulated by the TRIPS (Trade Related Aspects of Intellectual Property Rights) agreement of the World Trade Organization (WTO). The amendment, adopted at the Doha Conference in 2001 and subsequently clarified, provides for the right of a state, in the event of a national health emergency, to produce (or have a third-party produce) a drug without the permission of the company holding the patent on the product or its manufacturing process. In 2017, two-thirds of the WTO membership had ratified the amendment, making it operational.

The compulsory licence could facilitate the entry of new companies into the market, but it still leaves the problem of production capacity for high-technology medicines (such as new vaccines) unsolved.

A kind of ‘vaccine internationalism’ is called for by many. Its realization presupposes, however, the overcoming of barriers and conflicts, commercial and otherwise, between states, and of competition between economic groups; it involves the pooling of resources and productive capacity, the coordination and direction of the global production of vaccines and their distribution according to public needs worldwide. At the very least, it means stripping vaccines of their characteristics of a commodity, which is the form in which the products of human labour are presented in the capitalist social system.

The critics of neoliberalism and globalization stop at the threshold of criticizing the very foundations of the capitalist socio-economic formation. They instead lash out at the excessive power of the banks or the greed of the multinationals, etc., and cultivate the illusion that it is possible to eliminate some of these most odious, but inevitable, forms of capitalism in its imperialistic maturity. Lenin called this wishful thinking.

Production sites for Covid-19 vaccines in the EU and the UK.

Production sites for Covid-19 vaccines in the EU and the UK. In some plants (highlighted in red) the biological active substance is produced, in others the final stages of production, such as bottling and packaging, are carried out. Some of the facilities belong to the company that owns the vaccine, while more than half belong to companies that work on behalf of third parties (CDMO, Contract Development and Manufacturing Organization). Four vaccines are licensed in the EU (BioNTech/Pfizer, Oxford/AstraZeneca, Moderna and J&J); the others are under review by regulatory bodies (CureVac and Novavax) or are still undergoing clinical trials.

Sources: EDJNet — European Data Journalism Network, March 5th, European Commission; corporate communications.

Industrial powers in confrontation

Airfinity calculates that at the end of March the production of Covid-19 vaccines stood at 229 million doses in China, 164 in the US, 125 in India, 110 in the EU (three quarters of which are in Germany, Belgium and the Netherlands), and 16 in the UK. China exported 48%, India 44% and the EU 42%. The USA and the UK have kept all of their doses for their domestic markets [Airfinity, March 24th].

Internal Market Commissioner Thierry Breton believes the EU is winning the industrial battle: producing — he writes — over 200 million doses of vaccines, reaching current levels of production in the US, and the Union’s annual production capacity is expected to reach 3 billion doses by the end of the year. Breton also lays claim to the Union’s role as a top exporter worldwide. At least two-thirds of the 30 million doses administered in Britain were produced in Europe, and the UK depends on the EU for the second dose [European Commission, Beating COVID-19: Scale-up of vaccine production in Europe, April 8th].

Breton refers to 53 production sites for Covid-19 vaccines in Europe. 26% of the facilities are located in Germany. Together with the Netherlands and Belgium, the three countries host 40% of the sites, which in some cases produce more than one type of vaccine. In fact, at least thirty or so plants are owned by companies working on behalf of third parties (CDMO, Contract Development and Manufacturing Organization), of around ten nationalities, mostly German, Spanish and American.

The EU, writes Breton, is an industrial power that is and intends to remain a global player, rejecting vaccine nationalism. The European Commission has, however, since last January, made exports of vaccines subject to authorization. The EU, comments The Economist, is torn between its reputation as champion of open markets and the needs of internal supply [March 27th].

There is an ongoing struggle between the metropolises over health. The production capacity of vaccines, as well as the organisational efficiency in carrying out vaccination strategies — a precondition for a less or more rapid economic recovery — is a measure of the overall strength of states in the global competition.

Lotta Comunista, April 2021

Labels:

Popular posts from this blog

Uneven Development, Job Cuts, and the Crisis of Labour Under Global Capitalism

Internationalism No. 73, March 2025 Page 16 Uneven development is a fundamental law of capitalism. We have a macroscopic expression of this in the changing balance of power between States: Atlantic decline and Asian rise are the key dynamics behind the political processes of this era, including wars caused by the crisis in the world order. But behind all this there is a differentiated economic trend, starting from companies and sectors: hence the differentiated conditions for wage earners. And this is the element to keep in mind for an effective defensive struggle. It’s only the beginning The electrical and digital restructuring imposed by global market competition affects various production sectors. The car industry is the most obvious, due to the familiarity of the companies and brands involved. We have already reported on the agreement reached before Christmas at Volkswagen, which can be summarised as a reduction of 35,000 employees by 2030. Die Zeit [De...
Read more

The Works of Marx and Engels and the Bolshevik Model

Internationalism Pages 12–13 In the autumn of 1895 Lenin commented on the death of Friedrich Engels: "After his friend Karl Marx (who died in 1883), Engels was the finest scholar and teacher of the modern proletariat in the whole civilised world. […] In their scientific works, Marx and Engels were the first to explain that socialism is not the invention of dreamers, but the final aim and necessary result of the development of the productive forces in modern society. All recorded history hitherto has been a history of class struggle, of the succession of the rule and victory of certain social classes over others. And this will continue until the foundations of class struggle and of class domination – private property and anarchic social production – disappear. The interests of the proletariat demand the destruction of these foundations, and therefore the conscious class struggle of the organised workers must be directed against them. And every class strugg...
Read more

Bolsonaro Squeezed between Pandemic, Lula Card and Armed Forces

This article is taken from Intervenção Comunista — the journal of our Brazilian comrades We wrote in May last year that the ‘tropical Trump’ causes a perfect storm . This first quarter of the year seems to demonstrate this clearly: GDP decline (-4.1%) and increased unemployment (14.2%); an end to emergency aid and a delay in the resumption of a new, much leaner aid plan; a record number of deaths and Covid infections. With 2.7% of the world’s population, the country accounts for about 12% of Covid-19 deaths. In March alone, Brazil recorded an increase of about 33% in its daily deaths. The pandemic crisis, coupled with historical imbalances, is shaking up the dysfunctional government of Jair Bolsonaro, who has just appointed his fourth health minister in a year. Increased dependence on the Centrão The second half of Bolsonaro’s term began — for their politics — with the election of Arthur Lira (Progressive Party-Alagoas) as president of the Chamber of Deputies, and Rodrigo Pac...
Read more

Science Against Time

Internationalism No. 73, March 2025 Page 14 From the series Industry and pharmaceuticals The surge in China’s biopharmaceutical industry over the last decade is part of its broader scientific and technological ascent and therefore deserves our attention. Such growth presents a challenge to other imperialist powers. The Biosecure Act’s intention, to reduce the ties between American and Chinese biotech firms, has been branded by The Economist as “old-fashioned protectionism”. The British weekly recognises, however, that the clash goes well beyond a trade war. The stakes are higher. In a lengthy cover story [“The rise of Chinese science”], it writes that “China is now a leading scientific power”. Just five years ago, this was still considered only a possibility. The current question is whether this is “welcome or worrying” [June 15th, 2024]. Unity and scission The viewpoint of that publication, an authoritative voice of one of the power-houses of imperia...
Read more

British Nostalgia

From the series European News In his book Britain Alone , the Financial Times columnist Philip Stephens argues that David Cameron’s decision to hold the Brexit referendum in 2016 was self-serving […] The prime minister wanted to snuff out a Tory rebellion and to give himself a quieter life in 10 Downing Street . For short term tactical reasons, Cameron gambled on the strategic issue of Britain’s link to Europe. As for Boris Johnson, backing Brexit had been about personal ambition: establishing his claim to the leadership . In Stephens’ reconstruction of events, Brexit was an unwanted outcome for the leaders of the Leave campaign: When Boris Johnson and Michael Gove, […] appeared before the cameras on the morning of 24 June, they looked shell-shocked rather than triumphant. […] Winning was not part of the plan. However, once Brexit had been set in motion, Johnson pursued it with wild abandon and made it the cornerstone of his bid for No. 10. According to Stephens, there was no und...
Read more

German Socialism in 1917

Internationalism No. 78-79, August-September 2025 Page 6 From the series Pages from the history of the worker’s movement  According to Arrigo Cervetto [ Opere , Vol. 7], “paracentrism” is “the biggest obstacle to the formation of the worldwide Bolshevik party”. The Spartacists at Zimmerwald and Kiental Cervetto was analysing Lenin’s battle against centrism for the creation of the Third International, a battle which saw him isolated at Zimmerwald. He wrote down one of Zinoviev’s quotations from Histoire du parti communiste russe . “We were in the minority at Zimmerwald [1915]. […] In the years 1915 and 1916, we were nothing but an insignificant minority”. “But what is more serious?” – observed Cervetto – “is that the Zimmerwald Spartacists also said they were opposed to us”. In the strategic perspective of the “two separate halves” of socialism – the political conditions in Russia and the economic, productive, and social conditions in Germany – “for ...
Read more

Forces and Consequences of the New Strategic Phase

The new strategic phase in the world balance, with its new corresponding political cycles within powers, requires attention to the materialistic, historical and dialectical method of political analysis itself. The changing forces and basic trends need to be identified; we can make conjectures about the developments in single political battles, but the outcome of these battles will always require us to contemplate a plurality of solutions: some more probable. others less. but never Just a mechanical consequence of long-term economic movements. Many fixed points of the method of political analysis are usual tools in our Marxist elaboration, but this does not mean they must be taken for granted: it is of use to recall them, in relation to the new unknowns of the political battle. Men make their own history, but they do not make it just as they please; they do not make it under circumstances chosen by themselves, but under circumstances directly encountered, given and transmitted from t...
Read more

Crisis in Europe’s Auto Industry: Labour Struggles, Class Conflict, and the End of Social Partnership

Internationalism No. 71, January 2025 Page 16 We have on several occasions pointed to the automobile manufacturing sector as an indicator of the shifting economic and, consequently, political balance of power between States. It is inevitable that this also applies to the dynamics of the labour market and therefore to the balance of power between classes. A new social cycle The emergence of the Chinese imperialist giant is also shaking up social relations in the old metropolises. We have defined this moment as the descending phase of social-democratisation , the era in which the “conquests” of the previous ascending cycle are called into question. It is the phase in which what was believed to be guaranteed, including in terms of employment relationships, is in danger of being lost. What appears at first glance as merely an effect of technology (in this sector, specifically the development of the electric car) in fact reflects a more general shift in influenc...
Read more

Militarised Scientists

Internationalism No. 71, January 2025 Page 13 From the series Atom and industrialisation of science “ The bourgeoisie has stripped of its halo every occupation hitherto honoured and looked up to with reverent awe. It has converted the physician, the lawyer, the priest, the poet, the man of science, into its paid wage labourers ” [Marx and Engels, The Communist Manifesto ). The Manhattan Project scientists In Brighter Than a Thousand Suns: A Personal History of the Atomic Scientists , Robert Jungk [1913-1994] writes that the Manhattan Project was a labyrinth of winding paths and dead ends. Commenting on Jungk’s romanticised account of the first phase of the history of the atomic bomb, Edward Teller [1908-2003], often called the “father” of the H-bomb, wrote: “There is no mention of the futile efforts of the scientists in 1939 to awaken the interest of the military authorities in the atomic bomb. The reader does not learn about the dismay of scientists f...
Read more

Marx’s Logic

Internationalism No. 73, March 2025 Page 7 From the series Principles of Marxism The method of exposition in Marx’s economic analysis, which he summarised on various occasions, adopts the progression from the simplest to the most complex concepts. It is a method that, at first glance, appears to correspond to common sense — from easy to difficult — but which Marx explains by contradicting common sense. Common sense distorts knowledge, starting right from the elementary building blocks of the representation of reality, which requires scientific abstraction to understand. Opportunism will always set the prejudices of common sense against the science-party . Marx writes, introducing Volume I of Capital : “The value-form , whose fully developed shape is the money-form , is very elementary and simple. Nevertheless, the human mind has for more than 2,000 years sought in vain to get to the bottom of it, whilst on the other hand, to the successful analysis of ...
Read more